基于PubMed的阿尔茨海默病治疗药物研究热点双聚类分析(3)
參考文献
[1] Gonsalvez I，Baror R，Fried P，et al.Therapeutic Noninvasive Brain Stimulation in Alzheimer’s Disease[J].Curr Alzheimer Res，2017，14(4)：362-376.
[2] Jones S V，Kounatidis I.Nuclear Factor-Kappa B and Alzheimer Disease，Unifying Genetic and Environmental Risk Factors from Cell to Humans[J].Front Immunol，2017，8(1)：1805.
[3] Disease G B D，Injury I，Prevalence C.Global，regional，and national incidence，prevalence，and years lived with disability for 328 diseases and injuries for 195 countries，1990-2016：a systematic analysis for the Global Burden of Disease Study 2016[J].Lancet，2017，390(10100)：1211-1259.
, 百拇医药
[4] Wang J，Liu Y，Cheng X，et al.The Effects of LW-AFC on the Hippocampal Transcriptome in Senescence-Accelerated Mouse Prone 8 Strain，a Mouse Model of Alzheimer’s Disease[J].
J Alzheimers Dis，2017，57(1)：227-240.
[5] Cummings J L，Morstorf T，Zhong K.Alzheimer’s disease drug-development pipeline：few candidates，frequent failures[J].Alzheimers Res Ther，2014，6(4)：37.
[6] Kosenko E A，Tikhonova L A，Montoliu C，et al.Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer’s Disease[J].Front Neurosci，2017，11：728.
, 百拇医药
[7] Vergallo A，Giampietri L，Baldacci F，et al.Oxidative Stress Assessment in Alzheimer’s Disease：A Clinic Setting Study[J].Am J Alzheimers Dis Other Demen，2018，33(1)：35-41.
[8] Luo G，Liu M，He J，et al.Quetiapine attenuates recognition memory impairment and hippocampal oxidative stress in a transgenic mouse model of Alzheimer’s disease[J].Neuroreport，2014，25(9)：647-650.
[9] Yang R，Wang Q，Min L，et al.Monosialoanglioside improves memory deficits and relieves oxidative stress in the hippocampus of rat model of Alzheimer’s disease[J].Neurol Sci，2013，34(8)：1447-1451.
, http://www.100md.com
[10] Gu X H，Xu L J，Liu Z Q，et al.The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer’s disease [J].Behav Brain Res，2016，311(1)：309-321.
[11] Janson J，Eketjall S，Tunblad K，et al.Population PKPD modeling of BACE1 inhibitor-induced reduction in Abeta levels in vivo and correlation to in vitro potency in primary cortical neurons from mouse and guinea pig[J].Pharm Res，2014，31(3)：670-683.
, http://www.100md.com
[12] Tarazi H，Odeh R A，Al-Qawasmeh R，et al.Design，synthesis and SAR analysis of potent BACE1 inhibitors：Possible lead drug candidates for Alzheimer’s disease[J].Eur J Med Chem，2017，125：1213-1224.
[13] Haghighijoo Z，Firuzi O，Hemmateenejad B，et al.Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer’s disease[J].Bioorg Chem，2017，74：126-133., 百拇医药(郭钦惠 邓静君 钟桂平)
[1] Gonsalvez I，Baror R，Fried P，et al.Therapeutic Noninvasive Brain Stimulation in Alzheimer’s Disease[J].Curr Alzheimer Res，2017，14(4)：362-376.
[2] Jones S V，Kounatidis I.Nuclear Factor-Kappa B and Alzheimer Disease，Unifying Genetic and Environmental Risk Factors from Cell to Humans[J].Front Immunol，2017，8(1)：1805.
[3] Disease G B D，Injury I，Prevalence C.Global，regional，and national incidence，prevalence，and years lived with disability for 328 diseases and injuries for 195 countries，1990-2016：a systematic analysis for the Global Burden of Disease Study 2016[J].Lancet，2017，390(10100)：1211-1259.
, 百拇医药
[4] Wang J，Liu Y，Cheng X，et al.The Effects of LW-AFC on the Hippocampal Transcriptome in Senescence-Accelerated Mouse Prone 8 Strain，a Mouse Model of Alzheimer’s Disease[J].
J Alzheimers Dis，2017，57(1)：227-240.
[5] Cummings J L，Morstorf T，Zhong K.Alzheimer’s disease drug-development pipeline：few candidates，frequent failures[J].Alzheimers Res Ther，2014，6(4)：37.
[6] Kosenko E A，Tikhonova L A，Montoliu C，et al.Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer’s Disease[J].Front Neurosci，2017，11：728.
, 百拇医药
[7] Vergallo A，Giampietri L，Baldacci F，et al.Oxidative Stress Assessment in Alzheimer’s Disease：A Clinic Setting Study[J].Am J Alzheimers Dis Other Demen，2018，33(1)：35-41.
[8] Luo G，Liu M，He J，et al.Quetiapine attenuates recognition memory impairment and hippocampal oxidative stress in a transgenic mouse model of Alzheimer’s disease[J].Neuroreport，2014，25(9)：647-650.
[9] Yang R，Wang Q，Min L，et al.Monosialoanglioside improves memory deficits and relieves oxidative stress in the hippocampus of rat model of Alzheimer’s disease[J].Neurol Sci，2013，34(8)：1447-1451.
, http://www.100md.com
[10] Gu X H，Xu L J，Liu Z Q，et al.The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer’s disease [J].Behav Brain Res，2016，311(1)：309-321.
[11] Janson J，Eketjall S，Tunblad K，et al.Population PKPD modeling of BACE1 inhibitor-induced reduction in Abeta levels in vivo and correlation to in vitro potency in primary cortical neurons from mouse and guinea pig[J].Pharm Res，2014，31(3)：670-683.
, http://www.100md.com
[12] Tarazi H，Odeh R A，Al-Qawasmeh R，et al.Design，synthesis and SAR analysis of potent BACE1 inhibitors：Possible lead drug candidates for Alzheimer’s disease[J].Eur J Med Chem，2017，125：1213-1224.
[13] Haghighijoo Z，Firuzi O，Hemmateenejad B，et al.Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer’s disease[J].Bioorg Chem，2017，74：126-133., 百拇医药(郭钦惠 邓静君 钟桂平)
参见：首页 > 医疗版 > 疾病专题 > 精神内科 > 老年性痴呆